Targeting Heme Oxygenase-1 for Neuroprotection and Neuroinflammation in Neurodegenerative Diseases

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|11|12|1517-1531

ISSN： 1389-4501

Source： Current Drug Targets, Vol.11, Iss.12, 2010-12, pp. : 1517-1531

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Involvement of Heme Oxygenase-1 in Neuropsychiatric and Neurodegenerative Diseases

By  

Current Pharmaceutical Design, Vol. 24, Iss. 20, 2018-06 ,pp. : 2283-2302

Bentham Science Publishers

Access to resources Recommend Favorite

Heme Oxygenase-1 as a Therapeutic Target in Neurodegenerative Diseases and Brain Infections

By  

Current Pharmaceutical Design, Vol. 14, Iss. 5, 2008-02 ,pp. : 429-442

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Heme Oxygenase-1 in Vascular Disease

By  

Current Drug Targets, Vol. 11, Iss. 12, 2010-12 ,pp. : 1504-1516

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting TNF-Alpha to Elucidate and Ameliorate Neuroinflammation in Neurodegenerative Diseases

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 10, Iss. 3, 2011-05 ,pp. : 391-403

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting the Nrf2-Heme Oxygenase-1 Axis after Intracerebral Hemorrhage

By  

Current Pharmaceutical Design, Vol. 23, Iss. 15, 2017-06 ,pp. : 2226-2237

Bentham Science Publishers

Access to resources Recommend Favorite